Revolution Medicines, Inc. Warrant (RVMDW)
Market Closed
3 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
11. 45
+0.05
+0.4386%
$
45.18B Market Cap
- P/E Ratio
- Div Yield
80 Volume
- Eps
$ 11.4
Previous Close 
Want to track RVMDW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Revolution Medicines, Inc. Warrant (RVMDW) Statistics
Valuation metrics
Market Cap 45.18B
Enterprise value 44.02B
Trailing P/E (ttm) -23.46
Forward P/E -
PEG ratio 0.42
Price/Sales (ttm) -
Price/Book (mrq) 16.82
Enterprise Value/Revenue -
Enterprise Value/EBITDA -25.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.52K
Average volume (90 days) 43.81K
Price summary
52-Week low 0.16
52-Week high 13.29
Beta -
50-Day moving average 9.31
200-Day moving average 3.37
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.41%
Return on equity -0.96%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -8.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 18.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 11.38%
Book value per share (mrq) 12.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
